162 related articles for article (PubMed ID: 18758751)
1. Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells.
Chou CC; Hsu CY
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):1-9. PubMed ID: 18758751
[TBL] [Abstract][Full Text] [Related]
2. Differential expression changes in K562 cells during the hemin-induced erythroid differentiation and the phorbol myristate acetate (PMA)-induced megakaryocytic differentiation.
Huo XF; Yu J; Peng H; Du ZW; Liu XL; Ma YN; Zhang X; Zhang Y; Zhao HL; Zhang JW
Mol Cell Biochem; 2006 Nov; 292(1-2):155-67. PubMed ID: 16786195
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
Chou CC; Yung BY; Hsu CY
Life Sci; 2007 May; 80(22):2051-9. PubMed ID: 17448503
[TBL] [Abstract][Full Text] [Related]
4. [Chemical control of cell differentiation of human myeloleukemia K562 cell line].
Koiso Y; Nakajima O; Matsumura D; Fujimoto Y; Hashimoto Y
Yakugaku Zasshi; 2000 Jan; 120(1):104-12. PubMed ID: 10655786
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells.
Hong Y; Martin JF; Vainchenker W; Erusalimsky JD
Blood; 1996 Jan; 87(1):123-31. PubMed ID: 8547633
[TBL] [Abstract][Full Text] [Related]
6. Role of cholinergic agents in proliferation and caspase activity of hemin-induced erythroid differentiated K562 cells.
Cabadak H; Aydın B
J Recept Signal Transduct Res; 2020 Feb; 40(1):42-48. PubMed ID: 31910706
[No Abstract] [Full Text] [Related]
7. Evidence of the role of protein kinase C during aclacinomycin induction of erythroid differentiation in K562 cells.
Gillet R; Devemy E; Dupont C; Billat C; Jeannesson P; Trentesaux C
FEBS Lett; 1999 Jul; 454(3):331-4. PubMed ID: 10431833
[TBL] [Abstract][Full Text] [Related]
8. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
Lerga A; Crespo P; Berciano M; Delgado MD; Cañelles M; Calés C; Richard C; Ceballos E; Gutierrez P; Ajenjo N; Gutkind S; León J
Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells.
Yuan JY; Wang F; Yu J; Yang GH; Liu XL; Zhang JW
J Cell Mol Med; 2009; 13(11-12):4551-9. PubMed ID: 19017354
[TBL] [Abstract][Full Text] [Related]
10. Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP.
Hietakangas V; Poukkula M; Heiskanen KM; Karvinen JT; Sistonen L; Eriksson JE
Mol Cell Biol; 2003 Feb; 23(4):1278-91. PubMed ID: 12556488
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C-epsilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells.
Fagerström S; Påhlman S; Gestblom C; Nånberg E
Cell Growth Differ; 1996 Jun; 7(6):775-85. PubMed ID: 8780891
[TBL] [Abstract][Full Text] [Related]
12. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
Kucukkaya B; Arslan DO; Kan B
Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
[TBL] [Abstract][Full Text] [Related]
13. Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.
Solomon WB; Lin CH; Palma J; Gao XY; Wu S
J Biol Chem; 1993 Mar; 268(7):5089-96. PubMed ID: 8444885
[TBL] [Abstract][Full Text] [Related]
14. Modification by heme oxygenase inhibitor, tin protoporphyrin, of cellular differentiation of human myeloid leukemia K562 cell line.
Koiso Y; Fujimoto Y; Matsumura D; Nakajima O; Hashimoto Y
Biol Pharm Bull; 1999 Apr; 22(4):439-40. PubMed ID: 10328571
[TBL] [Abstract][Full Text] [Related]
15. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
Lee YL; Chen CW; Liu FH; Huang YW; Huang HM
PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
Meinhardt G; Roth J; Totok G
Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
[TBL] [Abstract][Full Text] [Related]
17. Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction.
Villeval JL; Pelicci PG; Tabilio A; Titeux M; Henri A; Houesche F; Thomopoulos P; Vainchenker W; Garbaz M; Rochant H; Breton-Gorius J; Edwards PA; Testa U
Exp Cell Res; 1983 Jul; 146(2):428-35. PubMed ID: 6575918
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation.
Murray NR; Baumgardner GP; Burns DJ; Fields AP
J Biol Chem; 1993 Jul; 268(21):15847-53. PubMed ID: 8340409
[TBL] [Abstract][Full Text] [Related]
19. c-FLIP is involved in erythropoietin-mediated protection of erythroid-differentiated cells from TNF-alpha-induced apoptosis.
Vittori D; Vota D; Callero M; Chamorro ME; Nesse A
Cell Biol Int; 2010 May; 34(6):621-30. PubMed ID: 20218968
[TBL] [Abstract][Full Text] [Related]
20. Role of protein kinase C in adriamycin-induced erythroid differentiation of K562 cells.
Hoffman R; Newlands ES
Cancer Chemother Pharmacol; 1991; 28(2):102-4. PubMed ID: 2060080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
